Brazil’s antitrust watchdog CADE approved the acquisition of ethanol producer Biosev by Raizen, a joint venture between Brazilian ethanol producer Cosan and Royal Dutch Shell.
The cash and stock deal was approved with no restrictions, according to the decision published on Tuesday, March 2, in Brazil’s official gazette.
Raizen will pay 3.6 billion reais (US$670.3 million) to Biosev shareholders, who will also receive 3.5% of Raizen preferred shares, plus 1.49% of redeemable shares, it said in a regulatory filing. The company declined to disclose the full purchase price.
The deal boosts Raizen’s position as the world’s largest sugar maker at a time when sugar prices are near the highest levels in four years. It also increases Raizen’s footprint in South America’s energy market.
After the acquisition, the company will operate 35 mills in Brazil with a sugar cane crushing capacity of 105 million tonnes per year, equivalent to 17% of Brazil’s center-south crop in 2019/20. Biosev and Raizen produced nearly 5 million tonnes of sugar and 3.84 billion liters of ethanol in 2019/20.
“It was a great opportunity. Biosev has good plants; they have a good operation. The problem there was financial, not operational,” Raizen’s Chief Executive Ricardo Mussa told Reuters.
Want more news? Subscribe to CPI’s free daily newsletter for more headlines and updates on antitrust developments around the world.
Featured News
UK Probes Lindab’s Acquisition of HAS-Vent Amid Fears of Market Monopoly
Apr 28, 2024 by
CPI
Shein Faces EU Regulations Over User Data
Apr 28, 2024 by
CPI
Google Fights Back Against US Antitrust Lawsuit
Apr 28, 2024 by
CPI
US Homeland Security Establishes Blue-Ribbon Board with Tech CEOs to Advise on AI
Apr 28, 2024 by
CPI
FTC Accuses Amazon Executives of Using Disappearing Messaging Apps to Conceal Evidence
Apr 28, 2024 by
CPI
Antitrust Mix by CPI
Antitrust Chronicle® – Economics of Criminal Antitrust
Apr 19, 2024 by
CPI
Navigating Economic Expert Work in Criminal Antitrust Litigation
Apr 19, 2024 by
CPI
The Increased Importance of Economics in Cartel Cases
Apr 19, 2024 by
CPI
A Law and Economics Analysis of the Antitrust Treatment of Physician Collective Price Agreements
Apr 19, 2024 by
CPI
Information Exchange In Criminal Antitrust Cases: How Economic Testimony Can Tip The Scales
Apr 19, 2024 by
CPI